Azz Inc (AZZ) · Oct 26, 2026 · Other events

AZZ investor presentation: raised guidance, bigger 2032 goals

FY2032 targets — $3.0B sales and 23% Adjusted EBITDA margin by FY2032

AZZ’s investor presentation mostly repackages its October 13 guidance raise while adding a longer-term $3 billion sales and 23% margin ambition.

AZZ is a North American hot-dip galvanizing and coil-coating operator in a growth-and-deleveraging phase, using strong Metal Coatings momentum, the Washington, Missouri plant ramp, and recent Seattle Galvanizing acquisition to extend FY2027 growth. Its October 13, 2026 second-quarter release had already reported record quarterly sales and raised FY2027 guidance, so this October 26 presentation is primarily a broader investor narrative rather than a fresh operating update.

The filing mostly confirms an already-known outlook. The presentation repeats the FY2027 guidance revised on October 13, lifting sales to $1.825–$1.875 billion, Adjusted EBITDA to $380–$420 million, and Adjusted diluted EPS to $7.00–$7.30 from the prior ranges of $1.80–$1.85 billion, $375–$415 million, and $6.75–$7.15, respectively. 〔0〕 Because the raise was already public before this filing, the presentation itself adds limited surprise.

MetricFY2026 actual / TTMFY2027 revised guidance or current figureLonger-term target
Sales$1.65B FY2026; $1.75B TTM$1.825–$1.875B$3.0B by FY2032
Adjusted EBITDA$367.6M FY2026; $383M TTM$380–$420M23% margin by FY2032
Adjusted diluted EPS$6.19 FY2026$7.00–$7.3015% CAGR goal
Net leverage1.3x TTM FY2027$100–$140M planned debt reduction~0.5x–1.5x target range

The genuinely incremental message is the length of the runway. AZZ now frames the business around a decade-long compounding model combining 5–7% organic growth, 3–5% M&A growth, and margin expansion from roughly 22% currently toward 23%. The filing states, “FY 2032 Goals: Sales $3.0B and Adjusted EBITDA 23%.” That is a strategic ambition, not a new commitment or near-term forecast, so it strengthens the narrative more than it changes the current earnings baseline.

Execution risk is concentrated in a few identifiable growth projects. The Washington facility is expected to be accretive in FY2027, with 75% of new capacity committed under multi-year take-or-pay contracts and only $1.4 million of remaining capital spending. 〔1〕 Those details make the ramp look better protected than a purely speculative greenfield build, while the 1.3x net leverage position preserves room for debt reduction, acquisitions, and shareholder returns.

Bottom line: This filing extends AZZ’s growth story but does not materially reset it. The near-term guidance raise was already known; the new contribution is a more ambitious long-term framework, with the Washington ramp as the main proof point still ahead.

What to watch next

Washington plant FY2027 ramp and earnings accretion

Original filing on SEC EDGAR

More Azz Inc news

AZZ investor presentation: raised guidance, bigger 2032 goals | AZZ Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.